Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy.

Zheng M

Open source

DOI
10.1016/j.seminoncol.2026.152567
Published
2026 Oct 9
Container
Seminars in oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.seminoncol.2026.152567,
  title = {Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy.},
  author = {Zheng M},
  year = {2026},
  journal = {Seminars in oncology},
  doi = {10.1016/j.seminoncol.2026.152567},
  url = {https://doi.org/10.1016/j.seminoncol.2026.152567}
}

RIS

TY  - JOUR
TI  - Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy.
AU  - Zheng M
PY  - 2026
JO  - Seminars in oncology
DO  - 10.1016/j.seminoncol.2026.152567
UR  - https://doi.org/10.1016/j.seminoncol.2026.152567
ER  - 

APA

M, Z. (2026). Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy.. Seminars in oncology. https://doi.org/10.1016/j.seminoncol.2026.152567

Source records